Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial – The Lancet Commentaries: Study: HIV drug of no benefit to hospitalized COVID patients – CIDRAP AND Antiviral monotherapy for hospitalised patients with COVID-19 is not enough – The Lancet AND   Commentary on Twitter NEW—Lopinavir-ritonavir is not an effective […]

The post Randomized trial: Lopinavir–ritonavir not beneficial for patients admitted to hospital with COVID-19 appeared first on Links Medicus.